Ploysyne Rattanakaemakorn

8PUBLICATIONS
9CO-AUTHORS
Gene and molecular therapyMedical biochemistry - carbohydratesInnate immunityAllergyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 18, 2025
Effect of Methotrexate Discontinuation on Psoriatic Patients with Significant Liver Fibrosis.

Tanat Yongpisarn, Kunlawat Thadanipon, Ploysyne Rattanakaemakorn

|Feb 11, 2025
Hyperglycemia Is a Potential Prognostic Factor for Exacerbation in Severe Psoriasis with Diabetes or Prediabetes.

Tanat Yongpisarn, Kunlawat Thadanipon, Poonkiat Suchonwanit

|Jan 13, 2023
A real-world prospective cohort study of immunogenicity and reactogenicity of ChAdOx1-S[recombinant] among patients with immune-mediated dermatological diseases.

Kumutnart Chanprapaph, Chutima Seree-Aphinan, Ploysyne Rattanakaemakorn

|Sep 06, 2022
Pityriasis Lichenoides Et Varioliformis Acuta and Lymphomatoid Papulosis Type F: A Case Report of Two Entities in One Patient.

Cherrin Pomsoong, Poonkiat Suchonwanit, Kumutnart Chanprapaph

|Jun 07, 2021
Incidence and Risk Factors of Hepatic Fibrosis in Psoriatic Patients Receiving Methotrexate with Concomitant Acitretin Therapy and Methotrexate Monotherapy.

Ploysyne Rattanakaemakorn, Prinpat Pinyowiwat, Wimolsiri Iamsumang

Pageof 2